Q3 2016 13F Holders as of 9/30/2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
112M
-
Number of holders
-
61
-
Total 13F shares, excl. options
-
18.8M
-
Shares change
-
-1.54M
-
Total reported value, excl. options
-
$161M
-
Value change
-
-$21.8M
-
Put/Call ratio
-
0.15
-
Number of buys
-
34
-
Number of sells
-
-22
-
Price
-
$8.54
Significant Holders of NovoCure Ltd - Common Stock (NVCR) as of Q3 2016
79 filings reported holding NVCR - NovoCure Ltd - Common Stock as of Q3 2016.
NovoCure Ltd - Common Stock (NVCR) has 61 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.8M shares
of 112M outstanding shares and own 16.81% of the company stock.
Largest 10 shareholders include FMR LLC (4.88M shares), VANGUARD GROUP INC (2.61M shares), HIGHLINE CAPITAL MANAGEMENT, L.P. (1.82M shares), StepStone Group LP (1.82M shares), BlackRock Fund Advisors (1.28M shares), PEREGRINE CAPITAL MANAGEMENT LLC (935K shares), STATE STREET CORP (864K shares), Tamarack Advisers, LP (775K shares), COURAGE CAPITAL MANAGEMENT LLC (500K shares), and BlackRock Institutional Trust Company, N.A. (469K shares).
This table shows the top 61 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.